TABLE 3.
Main characteristics of the included randomized controlled trials.
| References | Country | Population | Duration | Intervention | Placebo group | Dietary | MeDi score | Baseline age | Subjects (N) | Loss | Outcome method | Results |
| Hardman et al. (62) | Australia | Healthy older adults | 0.5 years | The diet group received a collection of recipes in keeping with MeDi diet style, and with the assistance of dietary consultants from Health Care 2 | Maintenance of their current lifestyle | FFQ | 0–9 | EG: 77.68 ± 7.38 CG: 78.22 ± 5.81 |
EG: 18 CG: 25 |
EG: 28% CG: 7% |
SUCCAB | The MeDi diet has the potential to improve aspects of cognition in aging population |
| Knight et al. (63) | Australia | Healthy older adults | 0.5 years | Participants were closely monitored on a fortnightly basis in an informed meeting that followed MeDi diet food pyramids | Participants were asked to simply maintain their customary lifestyle and dietary pattern | FFQ | 0–9 | EG: 72.1 ± 4.9 CG: 72.0 ± 5.0 |
EG: 70 CG: 67 |
EG: 19% CG: 17% |
A comprehensive battery of 11 cognitive tests | There was no beneficial effect of the MeDi diet intervention on cognitive function among healthy older adults |
| Martinez-Lapiscina et al. (64) | Spain | Cognitively normal participants at high CVD risk | 6.5 years | Participants received intensive education and advice to increase adherence to MeDi diet. Participants received free allotments of either EVOO (1 L/week) or 30 g/day of raw, unprocessed mixed nuts (15 g walnuts, 7.5 g almonds and 7.5 g hazelnuts) | Participants received intensive education and advice to increase adherence to the low-fat diet and received advice to reduce all types of fat and non-food gifts as an incentive to improve compliance | FFQ | 0–14 | All: 67.38 ± 5.65 | EGE: 224 EGN: 166 CG: 132 |
EGE: 36% EGN: 53% CG: 63% |
MMSE, CDT | An intervention with the MeDi diet enhanced with either EVOO or nuts appears to improve cognition compared with a low-fat diet |
| Sanchez-Villegas et al. (65) | Spain | Cognitively normal participants at high CVD risk | 3 years | The groups assigned to MeDi diet were advised to use extra virgin olive oil for cooking. Each participant had a personal interview with a trained dietician and a group session conducted by the same dietician every 3 months during these 4 years | Participants were advised to reduce all types of fat and were given recommendations according to the American guidelines | FFQ | 0–14 | EGE: 68.1 ± 6.1 EGN: 67.4 ± 5.7 CG: 68.0 ± 6.1 |
EGE: 91 EGN: 75 CG: 77 |
/ | ELISA kit | Adherence to the MeDi diet was associated to an improvement in plasma BDNF concentrations in individuals with depression and to prevent depression and cognitive decline |
| Valls-Pedret et al. (66) | Spain | Cognitively normal participants at high CVD risk | 4.1 years | Participants were educated on how to follow the MeDi diet and received supplemental foods at no cost. Participants received free allotments of either EVOO (1 L/week) or 30 g/day of raw, unprocessed mixed nuts (15 g walnuts, 7.5 g almonds and 7.5 g hazelnuts) | Participants were advised to reduce all dietary fat | FFQ | 0–14 | EGE: 67.9 ± 5.4 EGN: 66.7 ± 5.3 CG: 65.5 ± 5.8 |
EGE: 127 EGN: 112 CG: 95 |
EGE: 18% EGN: 24% CG: 34% |
MMSE, RAVLT, subtest of Wechsler memory scale, animal fluency test, Wechsler adult intelligence scale, CTT | The MeDi diet supplemented with olive oil or nuts was associated with improved cognitive function |
MeDi diet, Mediterranean diet; SUCCAB, Swinburne university computerized cognitive assessment battery; CDT, Clock drawing test; MMSE, Mini-Mental State Examination; EVOO, Extra virgin olive oil; EG, Experiment group; CG, Control group; EGE, Mediterranean diet plus Extra virgin olive oil; EGN, Mediterranean diet plus nuts; BDNF, Brain-derived neurotrophic factor; RAVLT, Rey Auditory Verbal Learning Test; CTT, Color trail test.